A raft of recalls; China orders drugs to meet monitoring rules; California wants big print on drug labels;

> The FDA says compounder Pentec Health is recalling its in-date nutritional prescriptions for renal patients because of  lack of sterility assurance associated with one of its laminar flow hoods used in compounding. Recall

> The FDA has issued a recall of all sterile products distributed by compounding pharmacy NuVision Pharmacy of Dallas, TX. Recall

> A subsidiary of India's Jubilant Life Sciences has recalled pantoprazole sodium from the U.S. market because of problems the FDA has with its manufacturing at its plant in Roorkee, India. Report

> The China Food and Drug Administration has notified drugmakers that it expects imported drugs in domestic packaging to comply with electronic monitoring regulations by November of this year and all other drugs to meet the standards by March 2014. Notice

> Beginning in the third quarter, Canada will require that API manufacturing meets the International Conference on Harmonization's Q7 Guidance on GMP. Item

> The Pharmaceutical Group of the European Union, European Association of Hospital Pharmacists and European Industrial Pharmacists Group have called on government regulators in Europe to find a solution for growing shortages of drugs. Release

And Finally... California is looking at requiring pharmacies to print drug labels in 12-point type to help patients read them better, but the industry says that might require oversized bottles. Story

 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.